Researchers have restored hearing in mice with ENPP1 deficiency using a novel bone-targeted enzyme replacement therapy, offering hope for treating hearing loss in patients with this rare and often fatal genetic disorder.
Understanding how and why people react to background noise could help in finding effective intervention strategies.
Elehear has officially launched its new advanced AI-driven OTC hearing aid featuring a new music mode and enhanced speech clarity.
Sensorion’s Phase 1/2 Audiogene trial of the gene therapy SENS-501 for infants and toddlers with OTOF-related congenital deafness shows promising early safety and hearing improvement data, particularly in one patient, with a higher dose cohort now underway.
The VisualEyes VNG update features new, data-driven assessments to help clinicians understand how patients function in daily activities.
Citadel Texas' Citadel Digital Signage software suite now features a new Android app and media player designed to boost customer engagement.
